Not So Different: A Podcast From The Center For Biosimilars

Biosimilars Check In: Vegzelma Launch, BLA Acceptances, China Approval FDA Issues Another CRL for Alvotech’s Adalimumab Biosimilar Multiple Infliximab Biosimilar Switches Appear Safe, Effective for Patients With IBD Study on Nonmedical Switching for Adalimumab Biosimilars Warns About Nocebo Effect Spherix Global Insights: Despite High Awareness, Provider Comfort With Adalimumab Biosimilars Is Low Pipelines and Preparation: How the US Can Prepare for More RA Biosimilars Study Reveals Factors That Dissuade Commercial Plans From Covering Biosimilars